Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI

Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI

To evaluate hepatobiliary-specific contrast agent (CA) mangafodipir trisodium (Mn-DPDP)–enhanced magnetic resonance imaging (MRI) for predicting the therapeutic efficacy of the vascular disrupting agent combretastatin A4 phosphate (CA4P) in rats with primary and secondary liver tumors, 36 primary he...

Full description

Bibliographic Details
Main Authors: Yewei Liu, Qiu Guan, Xiangyong Kong, Frederik De Keyzer, Yuanbo Feng, Feng Chen, Jie Yu, Jianjun Liu, Shaoli Song, Jos van Pelt, Johan Swinnen, Guy Bormans, Raymond Oyen, Shuncong Wang, Gang Huang, Yicheng Ni, Yue Li
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523319304620

Internet

http://www.sciencedirect.com/science/article/pii/S1936523319304620

Similar Items